Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future (vol 9, e001926, 2021)

被引：0

作者：

Alzeibak, R.

Mishchenko, T. A.

Shilyagina, N. Y.

机构：

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷 / 10期

关键词：

D O I：

10.1136/jitc-2020-001926corr1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：1

共 50 条

[41] Empirical identification and validation of tumo targeting T cell receptors from circulation using autologous pancreatic tumor organoids (vol 9, 9:e003213, 2021) [J].

Meng, Q. ;

Xie, S. ;

Gray, G. K. .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (05)

[42] In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis (vol 9, e001481, 2021) [J].

Kim, S. ;

Kim, S. A. ;

Nam, G. .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (10)

[43] Genomic profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: a secondary analysis of the CLAP trial (vol 9, e002223, 2021) [J].

Huang, Xin ;

He, Minjun ;

Peng, Hongyu ;

Tong, Chongjie ;

Liu, Zhimin .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (02)

[44] PD-L1 testing in non-small cell lung cancer: past, present, and future (vol 53, pg 199, 2019) [J].

Kim, Hyojin ;

Chung, Jin-Haeng .

JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2020, 54 (02) :196-196

[45] Complete metabolic response in patients with advanced non-small cell lung cancer with prolonged response to immune checkpoint inhibitor therapy (vol 9, e002262, 2021) [J].

Ferdinandus, J. ;

Metzenmacher, M. ;

Kessler, L. .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (06)

[46] Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer (vol 9, e002886, 2021) [J].

Zubiri, Leyre ;

Molina, Gabriel E. ;

Mooradian, Meghan J. ;

Cohen, Justine ;

Durbin, Sienna M. ;

Petrillo, Laura ;

Boland, Genevieve M. ;

Juric, Dejan ;

Dougan, Michael ;

Thomas, Molly F. ;

Faje, Alex T. ;

Rengarajan, Michelle ;

Guidon, Amanda C. ;

Chen, Steven T. ;

Okin, Daniel ;

Medoff, Benjamin D. ;

Nasrallah, Mazen ;

Kohler, Minna J. ;

Schoenfeld, Sara R. ;

Karp-Leaf, Rebecca S. ;

Sise, Meghan E. ;

Neilan, Tomas G. ;

Zlotoff, Daniel A. ;

Farmer, Jocelyn R. ;

Bardia, Aditya ;

Sullivan, Ryan J. ;

Blum, Steven M. ;

Semenov, Yevgeniy R. ;

Villani, Alexandra-Chloe ;

Reynolds, Kerry L. .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (10)

[47] RETRACTION: Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells (Retraction of Vol 8, art no E60975, 2013) [J].

Riganti, C. ;

Castella, B. ;

Kopecka, J. ;

Campia, I ;

Coscia, M. ;

Pescarmona, G. .

PLOS ONE, 2020, 15 (12)

[48] AKT Inhibitors Promote Cell Death in Cervical Cancer through Disruption of mTOR Signaling and Glucose Uptake (vol 9, e92948, 2014) [J].

Rashmi, R. ;

DeSelm, C. ;

Helms, C. ;

Bowcock, A. ;

Rogers, B. E. ;

Rader, Janet L. .

PLOS ONE, 2014, 9 (09)

[49] AKT Inhibitors Promote Cell Death in Cervical Cancer through Disruption of mTOR Signaling and Glucose Uptake (vol 9, e92948, 2014) [J].

Rader, Janet S. .

PLOS ONE, 2016, 11 (05)

[50] Photodynamic therapy induces human esophageal carcinoma cell pyroptosis by targeting the PKM2/caspase-8/caspase-3/GSDME axis (vol 520, pg 143, 2021) [J].

Li, Lisha ;

Song, Dongfeng ;

Qi, Ling ;

Jiang, Mingxia ;

Wu, Yiming ;

Gan, Junqing ;

Cao, Kui ;

Li, Yanjing ;

Bai, Yuxian ;

Zheng, Tongsen .

CANCER LETTERS, 2022, 525 :203-205

← 1 2 3 4 5 →